ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Panel Recommends Against Pooling Results Of NLST, European Studies, And I-ELCAP. NIH Director Zerhouni To Step Down At End Of October; Six-Year Tenure Brought Many Changes To NIH.

September 26, 2008

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Pressure Builds On President To Sign Authorization Bill; No Movement Yet On Appropriations Measure

November 8, 1985